Cargando…

CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study

BACKGROUND: Choosing patients with HIV/AIDS (PLWH) with virologic failure observed in the course of treatment, and analyzing the CD4(+) T cell count of PLWH with different subtypes of virus and the risk factors of CD4 (+) T cell count recovery METHODS: Analyze and evaluate the change of median CD4(+...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Dan, Zhang, Yan, Li, Yiping, Li, Ling, Yang, Hong, Yang, Wei, Yu, Hang, Feng, Liao, Liang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721127/
https://www.ncbi.nlm.nih.gov/pubmed/36478965
http://dx.doi.org/10.2147/IDR.S378799
_version_ 1784843701529346048
author Yuan, Dan
Zhang, Yan
Li, Yiping
Li, Ling
Yang, Hong
Yang, Wei
Yu, Hang
Feng, Liao
Liang, Shu
author_facet Yuan, Dan
Zhang, Yan
Li, Yiping
Li, Ling
Yang, Hong
Yang, Wei
Yu, Hang
Feng, Liao
Liang, Shu
author_sort Yuan, Dan
collection PubMed
description BACKGROUND: Choosing patients with HIV/AIDS (PLWH) with virologic failure observed in the course of treatment, and analyzing the CD4(+) T cell count of PLWH with different subtypes of virus and the risk factors of CD4 (+) T cell count recovery METHODS: Analyze and evaluate the change of median CD4(+) T cell count of PLWH infected with different HIV-1 subtypes in Sichuan Province after treatment by rank sum test. Univariate and multivariate logistic regression models were used to analyze the risk factors on CD4(+) T cell count growth after PLWH treatment. RESULTS: A total of 4977 cases were analysed, including CRF07_BC 2358 cases (47.38%), CRF01_AE 1507 cases (30.28%), CRF08_BC 577 cases (11.59%), CRF85_BC 303 cases (6.09%) and other subtypes 232 cases (4.66%). PLWH infected with CRF85_BC had lower median CD4(+) T cell count after treatment (p < 0.05). It was found that protective factors to increase CD4(+) T cell count (p < 0.05) including females, Yi people, married or cohabiting, educational level at primary school or above, initial and recent treatment with Tenofovir + Lamivudine + Nevirapine Wellen, the second-line regimen with lopinavir/ritonavir (LPV/r) and the treatment time is more than 24 months. However, over 50 years old, the disease course is in AIDS stage, the infection of CRF01_AE and CRF85_BC virus was the risk factor on CD4(+) T cell count increase (p < 0.05). PLWH with higher initial CD4 level had a lower ratio of CD4(+) T cell count increase (≥50 cells/μL) (p < 0.05). CONCLUSION: Age, sex, ethnicity, marriage, education, disease status, treatment protocols, treatment time, initial CD4(+) T cell count, and virus subtype are the influencing factors of PLWH CD4(+) T cell count increase. The poor recovery of CD4(+) T cell count after treatment was observed in PLWH infected with CRF85_BC virus.
format Online
Article
Text
id pubmed-9721127
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97211272022-12-06 CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study Yuan, Dan Zhang, Yan Li, Yiping Li, Ling Yang, Hong Yang, Wei Yu, Hang Feng, Liao Liang, Shu Infect Drug Resist Original Research BACKGROUND: Choosing patients with HIV/AIDS (PLWH) with virologic failure observed in the course of treatment, and analyzing the CD4(+) T cell count of PLWH with different subtypes of virus and the risk factors of CD4 (+) T cell count recovery METHODS: Analyze and evaluate the change of median CD4(+) T cell count of PLWH infected with different HIV-1 subtypes in Sichuan Province after treatment by rank sum test. Univariate and multivariate logistic regression models were used to analyze the risk factors on CD4(+) T cell count growth after PLWH treatment. RESULTS: A total of 4977 cases were analysed, including CRF07_BC 2358 cases (47.38%), CRF01_AE 1507 cases (30.28%), CRF08_BC 577 cases (11.59%), CRF85_BC 303 cases (6.09%) and other subtypes 232 cases (4.66%). PLWH infected with CRF85_BC had lower median CD4(+) T cell count after treatment (p < 0.05). It was found that protective factors to increase CD4(+) T cell count (p < 0.05) including females, Yi people, married or cohabiting, educational level at primary school or above, initial and recent treatment with Tenofovir + Lamivudine + Nevirapine Wellen, the second-line regimen with lopinavir/ritonavir (LPV/r) and the treatment time is more than 24 months. However, over 50 years old, the disease course is in AIDS stage, the infection of CRF01_AE and CRF85_BC virus was the risk factor on CD4(+) T cell count increase (p < 0.05). PLWH with higher initial CD4 level had a lower ratio of CD4(+) T cell count increase (≥50 cells/μL) (p < 0.05). CONCLUSION: Age, sex, ethnicity, marriage, education, disease status, treatment protocols, treatment time, initial CD4(+) T cell count, and virus subtype are the influencing factors of PLWH CD4(+) T cell count increase. The poor recovery of CD4(+) T cell count after treatment was observed in PLWH infected with CRF85_BC virus. Dove 2022-12-01 /pmc/articles/PMC9721127/ /pubmed/36478965 http://dx.doi.org/10.2147/IDR.S378799 Text en © 2022 Yuan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yuan, Dan
Zhang, Yan
Li, Yiping
Li, Ling
Yang, Hong
Yang, Wei
Yu, Hang
Feng, Liao
Liang, Shu
CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study
title CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study
title_full CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study
title_fullStr CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study
title_full_unstemmed CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study
title_short CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study
title_sort cd4(+) t cell count progress and influencing factors of recovery in aids patients with virological failure in sichuan province: a retrospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721127/
https://www.ncbi.nlm.nih.gov/pubmed/36478965
http://dx.doi.org/10.2147/IDR.S378799
work_keys_str_mv AT yuandan cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT zhangyan cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT liyiping cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT liling cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT yanghong cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT yangwei cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT yuhang cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT fengliao cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy
AT liangshu cd4tcellcountprogressandinfluencingfactorsofrecoveryinaidspatientswithvirologicalfailureinsichuanprovincearetrospectivecohortstudy